Skip to main content
SAFETY PROFILE OF SUBCUTANEOUS ABATACEPT FOCUSING ON CLINICALLY RELEVANT EVENTS IN PATIENTS WITH RHEUMATOID ARTHRITIS AND UP TO 4.5 YEARS OF EXPOSURE Annual Meeting of the British-Society-for-Rheumatology Alten, R., Kaine, J. L., Keystone, E., Nash, P. T., Delaet, I., Qi, K., Genovese, M. C. OXFORD UNIV PRESS. 2012: 127–128

View details for Web of Science ID 000302487900350